GRM5 and depressive symptom measurement: The node degrees of the genes, AKT1, APP, GRIN2B, CASP3, VEGFA, MAPK1, GRM5, and DRD2, were greater than 30, suggesting that these genes as potential targets are involved in the treatment of depression with ZZHPD.